238 related articles for article (PubMed ID: 18771817)
1. Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.
Christensen DZ; Bayer TA; Wirths O
Neurobiol Aging; 2010 Jul; 31(7):1153-63. PubMed ID: 18771817
[TBL] [Abstract][Full Text] [Related]
2. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA
Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993
[TBL] [Abstract][Full Text] [Related]
3. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
[TBL] [Abstract][Full Text] [Related]
4. Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment.
Bayer TA; Wirths O
Genes Brain Behav; 2008 Feb; 7 Suppl 1():6-11. PubMed ID: 18184366
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
Wirths O; Breyhan H; Marcello A; Cotel MC; Brück W; Bayer TA
Neurobiol Aging; 2010 May; 31(5):747-57. PubMed ID: 18657882
[TBL] [Abstract][Full Text] [Related]
6. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
7. Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse model.
Bayer TA; Breyhan H; Duan K; Rettig J; Wirths O
Neurodegener Dis; 2008; 5(3-4):140-2. PubMed ID: 18322372
[TBL] [Abstract][Full Text] [Related]
8. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.
Jawhar S; Trawicka A; Jenneckens C; Bayer TA; Wirths O
Neurobiol Aging; 2012 Jan; 33(1):196.e29-40. PubMed ID: 20619937
[TBL] [Abstract][Full Text] [Related]
9. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
[TBL] [Abstract][Full Text] [Related]
10. APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
Breyhan H; Wirths O; Duan K; Marcello A; Rettig J; Bayer TA
Acta Neuropathol; 2009 Jun; 117(6):677-85. PubMed ID: 19387667
[TBL] [Abstract][Full Text] [Related]
11. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
[TBL] [Abstract][Full Text] [Related]
13. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
14. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
[TBL] [Abstract][Full Text] [Related]
15. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.
Schmitz C; Rutten BP; Pielen A; Schäfer S; Wirths O; Tremp G; Czech C; Blanchard V; Multhaup G; Rezaie P; Korr H; Steinbusch HW; Pradier L; Bayer TA
Am J Pathol; 2004 Apr; 164(4):1495-502. PubMed ID: 15039236
[TBL] [Abstract][Full Text] [Related]
17. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E
Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
Weissmann R; Hüttenrauch M; Kacprowski T; Bouter Y; Pradier L; Bayer TA; Kuss AW; Wirths O
J Alzheimers Dis; 2016; 50(2):397-409. PubMed ID: 26639971
[TBL] [Abstract][Full Text] [Related]
19. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
[TBL] [Abstract][Full Text] [Related]
20. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]